Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. BMJ Case Rep. 2014;23:1-4.Dosi R, Ambaliya A, Joshi H, Patell R. Serotonin syndrome versus neuro- leptic malignant
An overview of serotonin syndrome (SS) vs neuroleptic malignant syndrome (NMS), including the different signs and symptoms and how to distinguish these conditions.
serotonin syndromeThe clinical manifestation of drug-induced abnormalities in thermoregulation occurs across a variety of drug mechanisms. The aim of this chapter is to review two of the most common drug-induced hyperthermic states, serotonin syndrome and neuroleptic malignant syndrome. Clinical features,...
(1960) in France as “syndrome malin des neuroleptiques”; and the French term was translated into English as “neuroleptic malignant syndrome” (Delay and Deniker, 1968) and became familiar in English-speaking countries around the world. However, the syndrome was reported only occasionally in ...
Serotonin syndrome vs. NMS Neuroleptic malignant syndrome (NMS)is similar to serotonin syndrome. This condition is rare but very serious. If it's not treated quickly, it can lead to death. But most people recover fully after treatment.
Epidemiology Neuroleptic malignant syndrome (NMS) is rare, diagnosed annually in 2,000 hospitalized patients in the US Recent studies suggest an incidence of 0.01–0.02% in patients treated with antipsychotic medications Risk factorsdoi:10.1007/978-1-4419-6842-5_27Panayiotis N. Varelas...
Here we test the validity of four assumptions that have become widely accepted: (1) The Hunter classification performs clinically better than the Sternbach and Radomski criteria; (2) in contrast to neuroleptic malignant syndrome, the onset of serotonin syndrome is usually rapid; (3) hyperthermia ...
A. Wilborn, “Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management,” Annals of Clinical Psychiatry, vol. 24, no. 2, pp. 155–162, 2012. [32] A. Graudins, A. Stearman, B. Chan, and K. Kulig, “Treatment of the serotonin syndrome ...
Bromocriptine A dopamine D2 receptor agonist used for the treatment of galactorrhea due to hyperprolactinemia and other prolactin-related conditions, as well as in early Parkinsonian Syndrome. Bufotenine A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mamma...
Neuroleptic malignant syndrome is a condition that affects patients who have recently been exposed to dopamine agonists or who are experiencing dopamine antagonist withdrawal. It mainly presents with alteration of mental status, ranging from agitation to hypoactive delirium, lead-pipe muscular rigidity, ...